The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke "CASTA"


Phase 4 Results N/A

Summary of Purpose

The study investigated the clinical efficacy and safety of a 10-day course of therapy with daily intravenous administration of 30mL Cerebrolysin based on a comparison with Placebo in patients with acute ischemic stroke. 1070 patients were randomized in this trial in 2 parallel groups, one receiving Cerebrolysin, the control group receiving Placebo. Study drug will be given once daily by intravenous infusion for...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 July 2011.

1 Sep 2006 23 Mar 2009 1 Oct 2010 1 Feb 2011 1 Jul 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available